Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors

Sami Jalil,Timo Keskinen,Juhana Juutila,Rocio Sartori Maldonado,Liliya Euro,Anu Suomalainen,Risto Lapatto,Emilia Kuuluvainen,Ville Hietakangas,Timo Otonkoski,Mervi E. Hyvönen,Kirmo Wartiovaara

DOI: https://doi.org/10.1016/j.ajhg.2024.03.004

2024-04-05

The American Journal of Human Genetics

Abstract:Harnessing CRISPR to correct a metabolic inherited disease, we developed a therapeutically relevant method to precisely edit the Finnish Founder pathogenic variant responsible for argininosuccinate lyase deficiency. By lipid-nanoparticle-mediated delivery of the adenosine base editor RNA, we achieve efficient gene editing and metabolic normalization in patient fibroblasts.

genetics & heredity